Table 1 Baseline characteristics of patients in the lower-TG (≦150 mg/dl) and higher-TG (>150 mg/dl) groups
Lower-TG group | Higher-TG group | P | |
|---|---|---|---|
N | 163 | 84 | |
Age, yrs | 67.1 ± 13.2 | 56.1 ± 11.3 | <0.001 |
Female (%) | 22 (13.6) | 19 (22.6) | 0.100 |
Hypertension (%) | 97 (59.5) | 61 (72.6) | 0.058 |
DM (%) | 46 (28.2) | 34 (40.5) | 0.071 |
Smoking (%) | 99 (60.7) | 56 (66.7) | 0.439 |
BMI, kg/m 2 | 24.1 ± 3.5 | 26.3 ± 3.2 | <0.001 |
Previous CAD (%) | 22 (13.5) | 5 (6.0) | 0.113 |
Previous stroke (%) | 15 (9.2) | 5 (6.0) | 0.522 |
Carotid stenosis (%) | 4 (2.5) | 0 (0) | 0.303 |
PAD (%) | 3 (1.8) | 2 (2.4) | 1.000 |
eGFR, ml/min | 46.7 ± 18.5 | 57.6 ± 20.5 | <0.001 |
Previous hypolipid drugs | |||
Statin | 21 (12.9) | 12 (14.3) | 0.913 |
Fibrate | 1 (0.6) | 3 (3.6) | 0.115 |
Admission lipid profile | |||
HDL, mg/dl | 45.4 ± 10.8 | 37.4 ± 8 | <0.001 |
LDL, mg/dl | 100.9 ± 31.6 | 106.6 ± 41.4 | 0.231 |
TC/HDL | 3.65 ± 0.87 | 5.02 ± 1.36 | <0.001 |
LDL/HDL | 2.32 ± 0.81 | 2.93 ± 1.28 | <0.001 |
TG, mg/dl (range) | 83.6 ± 34.3 (13–149) | 258.6 ± 136.8 (152–805) | <0.001 |
Cardiogenic shock (%) | 29 (17.8) | 7 (8.3) | 0.071 |